Jul-2026
Sales
Trend
6-Month
Product Count
SKUs
Avg Price
YoY Sales Change
YoY Price Change
Where to Buy
Remedy is stocked at 49 licensed dispensaries across Nevada, Oklahoma, and 2 other states, 46 of them in Nevada, with the deepest coverage in Las Vegas, Henderson, North Las Vegas, Reno, and Carson City. Search by ZIP code or city below to find the closest one, or filter by product type if you are after a specific format.
Market Insights Snapshot
In July 2026, Remedy’s mix concentrated in Flower at 49.31% share with 6.00% YoY growth and a 165.47% MoM surge, while Vapor Pens captured 37.40% share with 284.39% YoY and 343.91% MoM growth; together these two categories accounted for 86.71% of sales. Pre-Roll slipped to 4.87% share with a -77.83% YoY decline despite a 91.70% MoM rebound, and Concentrates held 7.79% share on 62.02% YoY and 43.08% MoM increases; Topical, though only 0.60% share, rose 107.10% YoY and 119.97% MoM, while Edible fell 45.10% MoM to 0.03% share. With overall brand sales up 20.02% YoY and average price up 32.84%, the pattern implies Remedy is pivoting toward higher-velocity inhalables led by a Vapor Pens spike while pruning lower-yield Edible and recovering Pre-Roll exposure.
The mix shift raises positioning stakes: the outsized 343.91% MoM and 284.39% YoY in Vapor Pens alongside a 165.47% MoM lift in Flower suggests Remedy is leaning into quick-turn, potency-forward formats, but the -77.83% YoY in Pre-Roll and 45.10% MoM drop in Edible indicate reduced breadth. At a 40 rank in Nevada Flower and a category-average price of $22.78 in Flower versus $39.90 in Vapor Pens, Remedy’s price architecture skews premium within pens and value within flower, implying a barbell that can win share rapidly in Vapor Pens while using Flower scale as a base, but it risks under-serving convenience seekers who migrate from Pre-Roll into Vapor Pens rather than back to Flower.
Competitive Landscape
Remedy sits at rank #40 in Nevada Flower in July 2026, a 10-place improvement from #50 year over year, and up 20 positions versus #60 three months ago, while still trailing its historical peak of #33 last reached in May 2025; meanwhile, STIIIZY climbed from #2 to #1 with 31.54% year-over-year sales growth as RYTHM slipped from #1 to #2 with a -12.69% decline, and Neon Moon surged from #10 to #3 alongside 52.71% growth, indicating Remedy’s rank rebound is real but occurs amid faster upward mobility at the top that raises the hurdle to re-enter the low-30s.

Notable Products
Key Lime Pie (3.5g) posted the largest month-over-month move at +308.5%, vaulting into rank 7 while OG 18 (3.5g) climbed +72.3% to rank 3. In contrast, Las Vegas Kush Cake (3.5g) fell -10.7% to rank 6 as Marmalade (3.5g) surged +182.6% into rank 10. With eight of the top ten as Flower SKUs and only one Pre-Roll in the mix, the pattern implies Remedy is consolidating around scalable 3.5g Flower formats that can swing share quickly, using occasional Pre-Roll spikes as tactical rather than structural volume drivers.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.







